Brokerages forecast that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will report sales of $713.96 million for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have provided estimates for Acadia Healthcare’s earnings. The lowest sales estimate is $708.90 million and the highest is $723.50 million. Acadia Healthcare posted sales of $702.89 million in the same quarter last year, which suggests a positive year over year growth rate of 1.6%. The firm is expected to report its next quarterly earnings results on Thursday, February 22nd.

On average, analysts expect that Acadia Healthcare will report full year sales of $713.96 million for the current year, with estimates ranging from $2.82 billion to $2.84 billion. For the next fiscal year, analysts forecast that the business will report sales of $3.01 billion per share, with estimates ranging from $2.99 billion to $3.06 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research firms that cover Acadia Healthcare.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Tuesday, October 24th. The company reported $0.58 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.65 by ($0.07). Acadia Healthcare had a net margin of 6.07% and a return on equity of 8.57%. The company had revenue of $716.70 million for the quarter, compared to analysts’ expectations of $728.86 million. During the same period in the previous year, the firm earned $0.58 earnings per share. The firm’s quarterly revenue was down 2.4% on a year-over-year basis.

Several equities analysts have commented on the company. Jefferies Group set a $42.00 price objective on Acadia Healthcare and gave the company a “buy” rating in a research report on Wednesday, October 25th. BMO Capital Markets assumed coverage on Acadia Healthcare in a research report on Monday, October 16th. They issued an “outperform” rating and a $52.00 price objective on the stock. Craig Hallum reaffirmed a “buy” rating and issued a $41.00 price objective (down previously from $65.00) on shares of Acadia Healthcare in a research report on Thursday, October 26th. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, October 2nd. Finally, Bank of America lowered their target price on Acadia Healthcare from $60.00 to $52.00 and set a “buy” rating for the company in a report on Wednesday, October 25th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $45.15.

Acadia Healthcare (NASDAQ:ACHC) traded down $1.07 during trading hours on Friday, reaching $31.83. The company’s stock had a trading volume of 1,787,300 shares, compared to its average volume of 1,349,360. The company has a market cap of $2,791.99, a P/E ratio of 13.88, a price-to-earnings-growth ratio of 1.18 and a beta of 0.89. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.30. Acadia Healthcare has a 1-year low of $26.92 and a 1-year high of $54.34.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Teacher Retirement System of Texas lifted its stake in shares of Acadia Healthcare by 0.4% during the 2nd quarter. Teacher Retirement System of Texas now owns 5,949 shares of the company’s stock worth $294,000 after purchasing an additional 26 shares during the last quarter. Public Employees Retirement Association of Colorado raised its stake in Acadia Healthcare by 0.9% in the second quarter. Public Employees Retirement Association of Colorado now owns 17,798 shares of the company’s stock valued at $879,000 after buying an additional 160 shares during the last quarter. Pacer Advisors Inc. raised its stake in Acadia Healthcare by 2.2% in the second quarter. Pacer Advisors Inc. now owns 10,365 shares of the company’s stock valued at $512,000 after buying an additional 226 shares during the last quarter. People s United Financial Inc. increased its holdings in shares of Acadia Healthcare by 3.4% in the second quarter. People s United Financial Inc. now owns 7,459 shares of the company’s stock valued at $368,000 after purchasing an additional 242 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Acadia Healthcare by 11.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,704 shares of the company’s stock valued at $134,000 after purchasing an additional 270 shares during the period.

WARNING: This news story was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another publication, it was illegally copied and republished in violation of international copyright & trademark law. The legal version of this news story can be read at https://www.americanbankingnews.com/2017/12/01/713-96-million-in-sales-expected-for-acadia-healthcare-company-inc-achc-this-quarter-2.html.

About Acadia Healthcare

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.

Get a free copy of the Zacks research report on Acadia Healthcare (ACHC)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.